|
US20160000902A1
(en)
*
|
2003-07-11 |
2016-01-07 |
Novavax, Inc. |
Combination vaccine for respiratory syncytial virus and influenza
|
|
DK2347775T3
(da)
|
2005-12-13 |
2020-07-13 |
Harvard College |
Skabeloner til celletransplantation
|
|
WO2009002401A2
(en)
|
2007-06-21 |
2008-12-31 |
President And Fellows Of Harvard College |
Scaffolds for cell collection or elimination
|
|
EP4206231A1
(en)
|
2007-12-24 |
2023-07-05 |
ID Biomedical Corporation of Quebec |
Recombinant rsv antigens
|
|
US9370558B2
(en)
|
2008-02-13 |
2016-06-21 |
President And Fellows Of Harvard College |
Controlled delivery of TLR agonists in structural polymeric devices
|
|
US10328133B2
(en)
|
2008-02-13 |
2019-06-25 |
President And Fellows Of Harvard College |
Continuous cell programming devices
|
|
EP3718566B1
(en)
*
|
2008-12-09 |
2024-06-12 |
Novavax, Inc. |
Modified rsv f proteins and methods of their use
|
|
US11446374B2
(en)
|
2008-12-09 |
2022-09-20 |
Novavax, Inc. |
Modified RSV F proteins and methods of their use
|
|
HRP20160798T1
(hr)
|
2009-06-24 |
2016-08-12 |
Glaxosmithkline Biologicals S.A. |
Rekombinantni antigeni iz rsv
|
|
AU2010264686A1
(en)
|
2009-06-24 |
2012-01-19 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
CN102639147B
(zh)
|
2009-07-15 |
2015-11-25 |
诺华股份有限公司 |
Rsv f 蛋白组合物和其制作方法
|
|
WO2011007961A2
(en)
*
|
2009-07-17 |
2011-01-20 |
Industry Academic Cooperation Foundation, Hallym University |
Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitpoes
|
|
JP5926180B2
(ja)
|
2009-07-31 |
2016-05-25 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
寛容原性療法のための細胞のプログラミングの方法
|
|
AU2010279492B2
(en)
*
|
2009-08-04 |
2015-04-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of The Health And Human Services, Centers For Disease Control And Prevention |
Anti-RSV immunogens and methods of immunization
|
|
CA2799934C
(en)
|
2010-07-07 |
2020-01-28 |
Artificial Cell Technologies, Inc. |
Respiratory syncytial virus antigenic compositions and methods
|
|
EP2624873B1
(en)
|
2010-10-06 |
2019-12-04 |
President and Fellows of Harvard College |
Injectable, pore-forming hydrogels for materials-based cell therapies
|
|
US20140024076A1
(en)
*
|
2011-01-28 |
2014-01-23 |
Medimmune, Llc. |
Expression Of Soluble Viral Fusion Glycoproteins In Mammalian Cells
|
|
EA034702B1
(ru)
*
|
2011-04-26 |
2020-03-10 |
Молекулар Экспресс, Инк. |
Липосомные композиции
|
|
US9675561B2
(en)
|
2011-04-28 |
2017-06-13 |
President And Fellows Of Harvard College |
Injectable cryogel vaccine devices and methods of use thereof
|
|
ES2685327T3
(es)
|
2011-04-28 |
2018-10-08 |
President And Fellows Of Harvard College |
Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
|
|
SG194755A1
(en)
|
2011-05-13 |
2013-12-30 |
Novartis Ag |
Pre-fusion rsv f antigens
|
|
EP2714073B1
(en)
|
2011-06-03 |
2021-03-10 |
President and Fellows of Harvard College |
In situ antigen-generating cancer vaccine
|
|
ES2395677B1
(es)
*
|
2011-07-29 |
2013-12-26 |
Instituto De Salud Carlos Iii |
Proteína F del VRSH en conformación pre-fusión estabilizada y anticuerpos neutralizantes específicos frente a la misma.
|
|
JP6085886B2
(ja)
|
2011-08-29 |
2017-03-01 |
国立大学法人徳島大学 |
Ｒｓｖ粘膜ワクチン
|
|
SG11201400999VA
(en)
*
|
2011-09-30 |
2014-07-30 |
Novavax Inc |
Recombinant nanoparticle rsv f vaccine for respiratory syncytial virus
|
|
JP2015514132A
(ja)
*
|
2012-04-10 |
2015-05-18 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
ヒト呼吸器合胞体ウイルスコンセンサス抗原、核酸構築物、およびそれらから作製されるワクチン、ならびにその使用方法
|
|
LT2838515T
(lt)
|
2012-04-16 |
2020-03-10 |
President And Fellows Of Harvard College |
Mezoporinės silico dioksido kompozicijos, skirtos imuninio atsako moduliavimui
|
|
PT2879702T
(pt)
*
|
2012-08-01 |
2020-02-04 |
Bavarian Nordic As |
Vacina para o vírus sincicial respiratório (rsv) de vírus vaccinia modificado recombinante ankara (mva)
|
|
EP3656396A1
(en)
*
|
2012-08-01 |
2020-05-27 |
Bavarian Nordic A/S |
Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
|
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
|
SG11201500573RA
(en)
|
2012-08-06 |
2015-02-27 |
Glaxosmithkline Biolog Sa |
Method for eliciting in infants an immune response against rsv and b. pertussis
|
|
SG11201506197TA
(en)
*
|
2013-02-11 |
2015-09-29 |
Novavax Inc |
Combination vaccine for respiratory syncytial virus and influenza
|
|
EP3030260A1
(en)
|
2013-08-05 |
2016-06-15 |
GlaxoSmithKline Biologicals S.A. |
Combination immunogenic compositions
|
|
WO2015168379A2
(en)
|
2014-04-30 |
2015-11-05 |
President And Fellows Of Harvard College |
Combination vaccine devices and methods of killing cancer cells
|
|
JP6664338B2
(ja)
|
2014-06-13 |
2020-03-13 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組合せ物
|
|
HK1247861A1
(zh)
|
2015-01-30 |
2018-10-05 |
President And Fellows Of Harvard College |
用於癌症治疗的肿瘤周围和肿瘤内部材料
|
|
CN107708756A
(zh)
|
2015-04-10 |
2018-02-16 |
哈佛学院院长等 |
免疫细胞捕获装置及其制备和使用方法
|
|
KR102758377B1
(ko)
|
2015-09-03 |
2025-01-23 |
노바백스, 인코포레이티드 |
개선된 안정성 및 면역원성을 갖는 백신 조성물
|
|
KR102136678B1
(ko)
|
2015-12-23 |
2020-07-22 |
화이자 인코포레이티드 |
Rsv f 단백질 돌연변이체
|
|
CN115487351A
(zh)
|
2016-02-06 |
2022-12-20 |
哈佛学院校长同事会 |
重塑造血巢以重建免疫
|
|
ES3032115T3
(en)
|
2016-07-13 |
2025-07-15 |
Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
WO2018026884A1
(en)
|
2016-08-02 |
2018-02-08 |
President And Fellows Of Harvard College |
Biomaterials for modulating immune responses
|
|
WO2018026941A1
(en)
|
2016-08-03 |
2018-02-08 |
Lonza Walkersville, Inc. |
Method of detecting an endotoxin using limulus amebocyte lysate substantially free of coagulogen
|
|
GB201620968D0
(en)
|
2016-12-09 |
2017-01-25 |
Glaxosmithkline Biologicals Sa |
Adenovirus polynucleotides and polypeptides
|
|
KR102545029B1
(ko)
*
|
2017-01-11 |
2023-06-19 |
론자 워커스빌 아이엔씨. |
맑고 밝게된 무-코아굴로겐 리물루스 아메바세포 용해물
|
|
JP7317796B2
(ja)
|
2017-07-24 |
2023-07-31 |
ノババックス，インコーポレイテッド |
呼吸器疾患を治療するための方法および組成物
|
|
CA3079048A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
Adenoviral vectors with two expression cassettes encoding rsv antigenic proteins or fragments thereof
|
|
WO2019076892A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
ENHANCED PROMOTER
|
|
WO2019076880A1
(en)
|
2017-10-16 |
2019-04-25 |
Glaxosmithkline Biologicals Sa |
SIMIENS ADENOVIRAL VECTORS COMPRISING TWO EXPRESSION CASSETTES
|
|
WO2019108541A1
(en)
*
|
2017-11-28 |
2019-06-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant rsv g proteins and their use
|
|
IL305911B2
(en)
|
2018-03-19 |
2025-01-01 |
Novavax Inc |
Multifunctional nanoparticle influenza vaccines
|
|
EP3807298A1
(en)
|
2018-06-12 |
2021-04-21 |
GlaxoSmithKline Biologicals S.A. |
Adenovirus polynucleotides and polypeptides
|
|
WO2020061129A1
(en)
|
2018-09-19 |
2020-03-26 |
President And Fellows Of Harvard College |
Compositions and methods for labeling and modulation of cells in vitro and in vivo
|
|
KR102725189B1
(ko)
|
2018-11-01 |
2024-10-31 |
에스케이바이오사이언스(주) |
재조합 호흡기 세포융합 바이러스 f 단백질 및 이를 포함하는 백신 조성물
|
|
KR102679227B1
(ko)
|
2019-02-28 |
2024-06-28 |
케이엠 바이올로직스 가부시키가이샤 |
Rsv f/g 키메라 백신
|
|
CN114993784B
(zh)
*
|
2022-05-27 |
2025-07-29 |
重庆医科大学 |
一种乙肝病毒颗粒裂解液及其制备与应用
|